Healthcare · Knowledge & Insight
Automate Product Operations in Medical Devices with AI
We design, build, and run AI-native product operations for medical device manufacturers, field service leaders, quality teams, and commercial operations. This page describes the engagement: scope, pricing, timeline, controls, and the KPIs we commit to.
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native product operations for medical devices is a phased engagement (Discovery 2 weeks → Build 8 weeks → Run continuous (4-week initial stabilization)) that ships a production workflow on top of QMS and CRM, moves feedback cycle time by −56% against the medical devices baseline, and is operated under knowledge & insight governance from day one.
Key facts
- Industry
- Medical Devices
- Use case
- Product Operations
- Intent cluster
- Knowledge & Insight
- Primary KPI
- feedback cycle time, roadmap confidence, launch readiness, and adoption
- Top benchmark
- Repeated-question volume: 100% (baseline) → 44% (−56%)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 2 weeks → Build 8 weeks → Run continuous (4-week initial stabilization)
- Team size
- 1 senior delivery + 1 part-time integration eng
- Discovery price
- $6k · 2-week sprint
- Build price
- $22k–$30k · 7-10 weeks
Primary outcome
connect feedback, roadmap, launch, and support data
What we ship
feedback classifier, roadmap insight system, launch assistant, and release communications workflow
KPIs we report on
feedback cycle time, roadmap confidence, launch readiness, and adoption
Why Medical Devices teams hire us for this
Most medical devices teams have already run an AI pilot. Most pilots stalled at "interesting demo, no production traffic, no measurable lift". AI-native delivery on product operations starts where those pilots stalled: from week one, the workflow runs on real medical devices data, real reviewers, and a baseline you can defend in a CFO review.
Foundational RAG research (Lewis et al., 2020) and follow-up work on long-context limitations (Liu et al., 2023) inform how we architect retrieval for medical devices: hybrid search + reranking + grounded citations, not raw long-context dumping.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of product operations in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
Repeated-question volume AI surfaces existing answers + flags content gaps for SME refresh | 100% (baseline) | 44% | −56% |
Decision cycle time Insight assembly compressed from manual deck-building to instrumented dashboard | 9 days | 1.5 days | −83% |
Cost per executive briefing Analyst time reallocated from assembly to validation and narrative | $1 800 | $340 | −81% |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
We treat the workflow as a system with five distinct layers: intake (classify and tag what comes in), context (retrieve approved sources), action (draft, route, decide), review (humans on low-confidence and high-impact cases), and learning (every reviewer action improves the next iteration). For product operations in medical devices, the layers are scoped during Discovery and built sequentially during Build.
What we build inside the workflow
The Build engagement ships three production layers. The intake layer classifies every request, record, or signal into a measurable taxonomy. The context layer retrieves approved source material — policy, customer history, prior cases, operational notes. The action layer clusters feedback, summarizes themes, drafts specs, prepares launch assets, and tracks adoption signals. Each layer is wrapped with review queues, confidence scoring, audit logs, and dashboards before any production traffic.
Reference architecture
4-layer AI-native workflow for knowledge & insight
Source intake → AI orchestration → Action → Human review & quality.See the full architecture diagram for Knowledge & Insight →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the traditional alternatives for product operations in medical devices.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | 6-12 months | 6-10 weeks (thin slice) |
| Pricing model | FTE hourly retainer or fixed staffing | Phased fixed-price (Discovery → Build → opt Run) |
| Audit / governance | Manual logs, periodic review | Versioned prompts, audit logs, reviewer queues, attestations |
| Operator throughput lift | 1.0× (baseline) | −83% |
| Cost per unit | Industry baseline | AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting. |
| Exit path | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Insight engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$6k
2-week sprint
Phase 2 · Build
$22k–$30k
7-10 weeks
Phase 3 · Run
$3k–$5k / mo
optional, hourly bank also available
~$34k–$60k typical year 1 (60% take the run option for ~6 months)
Source curation, retrieval architecture, evaluation harness, and decision dashboards.
Discovery is the only commitment to start. After Discovery, we scope Build with a fixed price. Run is opt-in, month-to-month, no lock-in.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We map the workflow, the systems, the decisions, and the baseline metrics. Output: a scoped statement of work.
Phase 2 · Weeks 2–4
Design
We design the operating model: data access, retrieval, prompts, review queues, controls, and the KPI dashboard.
Phase 3 · Weeks 4–8
Build
We ship a production thin slice on real data, with versioned prompts, evaluation harness, and human review.
Phase 4 · Weeks 8+
Run
We run the workflow with you weekly, expand into adjacent work, and report against baseline.
Interactive ROI calculator
Estimate your AI-native ROI for product operations
Reference inputs below are typical for medical devices teams in the knowledge insight cluster. Adjust them to match your situation.
Projected
Current monthly cost
$26,400
AI-native monthly cost
$6,684
Annual savings
$236,592
75% cost reduction · ~1,672 operator-hours freed / month
Governance and risk controls
The governance question that determines success in medical devices is rarely "is this model safe?" — it is "who owns the decision when the system is uncertain?". We answer that question explicitly for every step: named human owner, defined SLA, escalation path. quality management, clinical claims, product support, training accuracy, and complaint handling live in those ownership lines, not in the model weights.
How we report ROI
Medical Devices engagements on product operations have a predictable ROI shape: months 1-2 negative (engagement cost vs. limited production volume), month 3 break-even (full production traffic, baseline established), months 4-12 strongly positive (compounding leverage as the system tunes to your workflow). We forecast this shape during Discovery so the business case is clear before Build commits.
Common pitfall & mitigation
The failure mode we see most often on AI-native product operations engagements in medical devices contexts.
Decision dashboards become wallpaper
Beautiful dashboards, no action; the metric moved but nobody noticed
Alerting on metric movement + named owner per metric + weekly action review in Run
Build internally or work with us
The build-vs-buy decision in medical devices usually comes down to four constraints: do you have AI engineering capacity, do you have ops capacity to govern it, do you have time-to-value pressure, and do you have a reference architecture to copy. We bring all four to an engagement. If you have two or fewer, working with us is faster and cheaper than building.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move feedback cycle time, roadmap confidence, launch readiness, and adoption within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
The best first project for AI-native product operations in medical devices is a contained workflow with enough volume to matter and enough structure to evaluate. Avoid the most politically sensitive process first. Avoid a workflow with no measurable baseline. Choose a process where we can ship a production-grade thin slice, prove adoption, and then extend the same architecture to neighboring work.
A practical target is a 30-day build followed by a 60-day operating period. In the first 30 days, we map the work, connect the minimum data sources, build the assistant, and create the review process. In the next 60 days, the system handles real volume, the team measures outcomes, and we improve the workflow weekly. By day 90, leadership knows whether to expand into adjacent work.
Frequently asked questions
How do you automate product operations in medical devices with AI?+
We map the existing product operations workflow inside medical devices, identify the high-volume, high-structure tasks, and build an AI agent that handles those tasks while routing low-confidence cases to a human reviewer. The build connects to your QMS, CRM, field service platforms, runs against a labelled test set, and ships behind a reviewer queue before it sees production traffic. We then operate it, measure feedback cycle time, roadmap confidence, launch readiness, and adoption, and improve it weekly.
What does it cost to automate product operations for a medical devices company?+
Three phases, billed separately. Discovery sprint: $6k (2-week sprint). Build engagement: $22k–$30k (7-10 weeks). Run retainer: $3k–$5k / mo (optional, hourly bank also available). ~$34k–$60k typical year 1 (60% take the run option for ~6 months). Source curation, retrieval architecture, evaluation harness, and decision dashboards.
What is the best AI agent for product operations in medical devices?+
There is no single "best" off-the-shelf agent for product operations in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI product operations for medical devices?+
A thin-slice deployment in 2-week sprint after Discovery, with real medical devices data and real reviewers. The full Build phase runs 7-10 weeks. By day 90, feedback cycle time, roadmap confidence, launch readiness, and adoption is instrumented, the team has a baseline, and leadership has the data needed to decide on expansion into adjacent medical devices workflows.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
How do you guarantee AI answer quality for product operations in medical devices?+
We curate sources, run an evaluation harness against a labelled test set, and require citations for every generated answer. We report on feedback cycle time, roadmap confidence, launch readiness, and adoption and on test-set accuracy weekly.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- OECD AI Principles — OECD
- EU AI Act — European Commission
- Retrieval-Augmented Generation for Knowledge-Intensive NLP Tasks — Lewis et al., Meta AI Research
- Lost in the Middle: How Language Models Use Long Contexts — Liu et al., Stanford
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Start the engagement
Book a discovery call for Medical Devices
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.